Aromatase Therapy Timing Key in Breast Cancer Survival (CME/CE)

posted on Aug 23 by MedPage Today OB/Gyn in the Uncategorized category (MedPage Today) -- Breast cancer patients treated with endocrine therapy might improve their odds for survival by starting with tamoxifen and then switching to an aromatase inhibitor, authors of a meta-analysis concluded.